151 related articles for article (PubMed ID: 31055666)
1. Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis.
Dohzono S; Sasaoka R; Takamatsu K; Hoshino M; Nakamura H
Support Care Cancer; 2020 Jan; 28(1):389-394. PubMed ID: 31055666
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of paravertebral muscle density in patients with spinal metastases from gastrointestinal cancer.
Dohzono S; Sasaoka R; Takamatsu K; Hoshino M; Nakamura H
Support Care Cancer; 2019 Apr; 27(4):1207-1213. PubMed ID: 30220027
[TBL] [Abstract][Full Text] [Related]
3. Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study.
Cortellini A; Bozzetti F; Palumbo P; Brocco D; Di Marino P; Tinari N; De Tursi M; Agostinelli V; Patruno L; Valdesi C; Mereu M; Verna L; Lanfiuti Baldi P; Venditti O; Cannita K; Masciocchi C; Barile A; McQuade JL; Ficorella C; Porzio G
Sci Rep; 2020 Jan; 10(1):1456. PubMed ID: 31996766
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery.
Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
Lung Cancer; 2020 Sep; 147():71-76. PubMed ID: 32673829
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of low psoas muscle mass in patients with cervical spine metastasis.
Dohzono S; Sasaoka R; Takamatsu K; Hoshino M; Nakamura H
J Clin Neurosci; 2019 Aug; 66():56-60. PubMed ID: 31153754
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer.
Degens JHRJ; Sanders KJC; de Jong EEC; Groen HJM; Smit EF; Aerts JG; Schols AMWJ; Dingemans AC
Lung Cancer; 2019 Jul; 133():130-135. PubMed ID: 31200819
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of psoas major muscle density in patients with breast cancer metastases to bone: a retrospective single-center cohort study.
Yao H; Dohzono S; Sasaoka R; Takamatsu K; Nakamura H
Jpn J Clin Oncol; 2022 Jan; 52(1):8-13. PubMed ID: 34642753
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of body mass index in small-cell lung cancer: Exploring the relationship with skeletal muscle status.
Kwon YJ; Yoon YC; Kim HS; Cha MJ; Park S; Lee JH
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2939-2947. PubMed ID: 37986687
[TBL] [Abstract][Full Text] [Related]
9. Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy.
Cortellini A; Palumbo P; Porzio G; Verna L; Giordano AV; Masciocchi C; Parisi A; Cannita K; Ficorella C; Bozzetti F
Thorac Cancer; 2018 Dec; 9(12):1623-1630. PubMed ID: 30259689
[TBL] [Abstract][Full Text] [Related]
10. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.
Tanaka S; Ozeki N; Mizuno Y; Nakajima H; Hattori K; Inoue T; Nagaya M; Fukui T; Nakamura S; Goto M; Sugiyama T; Nishida Y; Chen-Yoshikawa TF
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):646-656. PubMed ID: 33665984
[TBL] [Abstract][Full Text] [Related]
11. Application of morphometric analysis to patients with lung cancer metastasis to the spine: a clinical study.
Zakaria HM; Basheer A; Boyce-Fappiano D; Elibe E; Schultz L; Lee I; Siddiqui F; Griffith B; Chang V
Neurosurg Focus; 2016 Aug; 41(2):E12. PubMed ID: 27476836
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different 2D muscle indexes measured at the level of the 3rd lumbar vertebra in survival prediction in patients with renal cell carcinoma.
Janhunen O; Jokelainen O; Peltoniemi R; Nykopp TK; Arponen O
Acta Oncol; 2024 May; 63():330-338. PubMed ID: 38745483
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.
Taguchi S; Akamatsu N; Nakagawa T; Gonoi W; Kanatani A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Homma Y
Clin Genitourin Cancer; 2016 Jun; 14(3):237-43. PubMed ID: 26337653
[TBL] [Abstract][Full Text] [Related]
14. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.
Tao J; Fang J; Chen L; Liang C; Chen B; Wang Z; Wu Y; Zhang J
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2591-2601. PubMed ID: 37724690
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
Takamori S; Tagawa T; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Honda H; Maehara Y
Ann Thorac Surg; 2020 Mar; 109(3):914-920. PubMed ID: 31655044
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer.
Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Akazawa A
PLoS One; 2021; 16(9):e0257594. PubMed ID: 34551011
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y
Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia Predicts Overall Survival in Patients with Lung, Breast, Prostate, or Myeloma Spine Metastases Undergoing Stereotactic Body Radiation Therapy (SBRT), Independent of Histology.
Zakaria HM; Llaniguez JT; Telemi E; Chuang M; Abouelleil M; Wilkinson B; Chandra A; Boyce-Fappiano D; Elibe E; Schultz L; Siddiqui F; Griffith B; Kalkanis SN; Lee IY; Chang V
Neurosurgery; 2020 May; 86(5):705-716. PubMed ID: 31232439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
